These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21327030)

  • 1. Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions.
    Viswanathan VK; Mallozzi MJ; Vedantam G
    Gut Microbes; 2010 Jul; 1(4):234-242. PubMed ID: 21327030
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Schäffler H; Breitrück A
    Front Microbiol; 2018; 9():646. PubMed ID: 29692762
    [No Abstract]   [Full Text] [Related]  

  • 3. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clostridium difficile isolation in children hospitalized with diarrhea].
    Santiago B; Guerra L; García-Morín M; González E; Gonzálvez A; Izquierdo G; Martos A; Santos M; Navarro M; Hernández-Sampelayo MT; Saavedra-Lozano J
    An Pediatr (Barc); 2015 Jun; 82(6):417-25. PubMed ID: 25217386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya.
    Oyaro MO; Plants-Paris K; Bishoff D; Malonza P; Gontier CS; DuPont HL; Darkoh C
    Int J Infect Dis; 2018 Sep; 74():24-28. PubMed ID: 29960098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current knowledge on the laboratory diagnosis of
    Martínez-Meléndez A; Camacho-Ortiz A; Morfin-Otero R; Maldonado-Garza HJ; Villarreal-Treviño L; Garza-González E
    World J Gastroenterol; 2017 Mar; 23(9):1552-1567. PubMed ID: 28321156
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on Clostridium difficile infections.
    Le Monnier A; Zahar JR; Barbut F
    Med Mal Infect; 2014 Aug; 44(8):354-65. PubMed ID: 25156678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile outbreaks: prevention and treatment strategies.
    Martinez FJ; Leffler DA; Kelly CP
    Risk Manag Healthc Policy; 2012; 5():55-64. PubMed ID: 22826646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology.
    Elliott B; Androga GO; Knight DR; Riley TV
    Infect Genet Evol; 2017 Apr; 49():1-11. PubMed ID: 28012982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the Microbiome: Applications to Clostridium difficile Infection.
    Culligan EP; Sleator RD
    J Clin Med; 2016 Sep; 5(9):. PubMed ID: 27657145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients.
    Iwashima Y; Nakamura A; Kato H; Kato H; Wakimoto Y; Wakiyama N; Kaji C; Ueda R
    J Infect Chemother; 2010 Oct; 16(5):329-33. PubMed ID: 20449624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial-acquired and community-onset Clostridium difficile infection at an academic hospital in Italy: Epidemiology, recurrences and toxin genes distribution.
    Visconti V; Brunetti G; Cuomo MR; Giordano A; Raponi G
    J Infect Chemother; 2017 Nov; 23(11):763-768. PubMed ID: 28899610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection.
    Villafuerte Gálvez JA; Kelly CP
    Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):611-622. PubMed ID: 28636484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Diagnostic Algorithm for the Detection of Clostridium difficile-Associated Diarrhea.
    Yoldaş Ö; Altındiş M; Cufalı D; Aşık G; Keşli R
    Balkan Med J; 2016 Jan; 33(1):80-6. PubMed ID: 26966622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.
    Chen S; Gu H; Sun C; Wang H; Wang J
    Infection; 2017 Jun; 45(3):255-262. PubMed ID: 27601055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.
    Vedantam G; Clark A; Chu M; McQuade R; Mallozzi M; Viswanathan VK
    Gut Microbes; 2012; 3(2):121-34. PubMed ID: 22555464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic.
    Hell M; Bernhofer C; Stalzer P; Kern JM; Claassen E
    Benef Microbes; 2013 Mar; 4(1):39-51. PubMed ID: 23434948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
    Kim J; Pai H; Seo MR; Kang JO
    J Korean Med Sci; 2011 Oct; 26(10):1258-64. PubMed ID: 22022175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical epidemiology of Clostridium difficile infection among hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Lopes Cançado GG; Silveira Silva RO; Rupnik M; Nader AP; Starling de Carvalho J; Miana de Mattos Paixão G; Martins Resende BA; Faria Lobato FC; Vilela EG
    Anaerobe; 2018 Dec; 54():65-71. PubMed ID: 30114442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.